Neurotrophic Factors in Neurodegenerative Disorders Potential for Therapy

被引:33
作者
Fumagalli, Fabio [1 ]
Molteni, Raffaella [1 ]
Calabrese, Francesca [1 ]
Maj, Paola Francesca [1 ]
Racagni, Giorgio [1 ,2 ]
Riva, Marco Andrea [1 ]
机构
[1] Univ Milan, Ctr Neuropharmacol, Dept Pharmacol Sci, I-20133 Milan, Italy
[2] IRCCS San Giovanni Diofatebenefratelli, Brescia, Italy
关键词
D O I
10.2165/0023210-200822120-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Finding an effective therapy to treat chronic neurodegenerative disorders still represents an unmet and elusive goal, mainly because so many pathogenic variables come into play in these diseases. Recent emphasis has been placed on the role of neurotrophic factors in the aetiology of such disorders because of their role in the survival of different cell phenotypes under various adverse conditions, including neurodegeneration. This review summarizes the current status and the efforts to treat neurodegenerative disorders by the exogenous administration of neurotrophic factors in an attempt to replenish trophic supply, the paucity of which may contribute to the development of the illness. Although promising results have been seen in animal models, this approach still meets disparate and often insurmountable problems in clinical settings, presumably related to the unique nature of the human being.
引用
收藏
页码:1005 / 1019
页数:15
相关论文
共 177 条
[1]   Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy [J].
Acsadi, G ;
Anguelov, RA ;
Yang, HB ;
Toth, G ;
Thomas, R ;
Jani, A ;
Wang, YY ;
Ianakova, E ;
Mohammad, S ;
Lewis, RA ;
Shy, ME .
HUMAN GENE THERAPY, 2002, 13 (09) :1047-1059
[2]   CHOLINERGIC NEURONOTROPIC FACTORS - INTRA-OCULAR DISTRIBUTION OF TROPHIC ACTIVITY FOR CILIARY NEURONS [J].
ADLER, R ;
LANDA, KB ;
MANTHORPE, M ;
VARON, S .
SCIENCE, 1979, 204 (4400) :1434-1436
[3]   Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients [J].
Aebischer, P ;
Schluep, M ;
Deglon, N ;
Joseph, JM ;
Hirt, L ;
Heyd, B ;
Goddard, M ;
Hammang, JP ;
Zurn, AD ;
Kato, AC ;
Regli, F ;
Baetge, EE .
NATURE MEDICINE, 1996, 2 (06) :696-699
[4]   Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons [J].
Åkerud, P ;
Alberch, J ;
Eketjäll, S ;
Wagner, J ;
Arenas, E .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (01) :70-78
[5]   Exogenous NGF restores endogenous NGF distribution in the brain of the cognitively impaired aged rat [J].
Albeck, D ;
Mesches, MH ;
Juthberg, S ;
Browning, M ;
Bickford, PC ;
Rose, GM ;
Granholm, AC .
BRAIN RESEARCH, 2003, 967 (1-2) :306-310
[6]   Neurotrophic factors in Huntington's disease [J].
Alberch, J ;
Pérez-Navarro, E ;
Canals, JM .
NGF AND RELATED MOLECULES IN HEALTH AND DISEASE, 2004, 146 :195-229
[7]   A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease [J].
Alvarez, XA ;
Cacabelos, R ;
Laredo, M ;
Couceiro, V ;
Sampedro, C ;
Varela, M ;
Corzo, L ;
Fernandez-Novoa, L ;
Vargas, M ;
Aleixandre, M ;
Linares, C ;
Granizo, E ;
Muresanu, D ;
Moessler, H .
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (01) :43-54
[8]   Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF [J].
Bachoud-Lévi, AC ;
Déglon, N ;
Nguyen, JP ;
Bloch, J ;
Bourdet, C ;
Winkel, L ;
Rémy, P ;
Goddard, M ;
Lefaucheur, JP ;
Brugières, P ;
Baudic, S ;
Cesaro, P ;
Peschanski, M ;
Aebischer, P .
HUMAN GENE THERAPY, 2000, 11 (12) :1723-1729
[9]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[10]  
Beck M, 2005, AMYOTROPH LATERAL SC, V6, P100, DOI 10.1080/14660820510028412